Google DeepMind spinoff Isomorphic Labs expects testing on its first AI-designed drugs to begin this year, as tech startups ...

Google's DeepMind spinoff Isomorphic Labs expects clinical trial of drugs it designed using AI to start this year.

AI creatives with access to Google’s Veo 2 text-to-video tool say it’s another “leap forward” for video generation Veo 2 ...

The CEO of Google Mind has suggested clinical trials of the first drugs designed with the help of AI could begin this year.

The order, signed in October 2023, required companies building powerful AI systems to share their safety test results with the federal government and come up with ways to limit their models’ biases ...

Demis Hassabis is the CEO of Google DeepMind. Demis thinks new agent type systems will be able to perform additional tree of knowledge search to achieve ...

The company fulfilled requests from Israel’s military for more access to AI tools as it sought to compete with Amazon, ...

Google DeepMind AI for Science Scholarships are now available, offering African students the opportunity to pursue ...

Isomorphic was spun out of Google’s AI research arm Google DeepMind in 2021, but remains a wholly owned subsidiary of its ...

Google DeepMind Chief Operations Officer Lila Ibrahim discussed the changes that the Trump administration may bring, ...

The headlines are the Galaxy S25 line-up, but the hardware is powered by Samsung's ambition to develop an AI ecosystem ...

Researchers are identifying current and future dangers within AI models away from the conflicts of interest they’d face in ...